xanomeline 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
cholinergic agents (muscarine receptor agonists/partial antagonists used in the treatment of Alzheimer's disease) 3652 131986-45-3

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • xanomeline
  • LY246708
  • xanomeline tartrate
  • LY-246708
a cholinergic agonist; used in the treatment of Alzheimer's disease; structure given in first source
  • Molecular weight: 281.42
  • Formula: C14H23N3OS
  • CLOGP: 4.42
  • LIPINSKI: 0
  • HAC: 4
  • HDO: 0
  • TPSA: 38.25
  • ALOGS: -3.57
  • ROTB: 7

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

External reference:

Pharmaceutical products:

None

xanomeline